Nasdaq

Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the ...
Nasdaq

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of ...
Seeking Alpha

Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations

MALVERN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the ...
MD&M East

Neuronetics Nabs FDA Clearance for NeuroStar Treatment in Adolescents

Neuronetics, a medtech company focused on neurohealth disorders, today announced the FDA clearance of its NeuroStar Advanced Therapy for use as an adjust for the treatment of major depressive disorder ...
Seeking Alpha

Neuronetics Launches Innovations To NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform

MALVERN, Pa., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the ...
Business Insider

NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment

MALVERN, Pa., Nov. 13, 2018 /PRNewswire/ -- NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), announced an expanded partnership with GRW Health, the ...
Business Insider

NeuroStar® Advanced Therapy to Receive Reimbursement Approval in Japan

MALVERN, Pa., March 27, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve ...
Fierce Healthcare

Evernorth expands coverage of NeuroStar depression therapy to adolescents

Cigna's Evernorth unit is expanding coverage for Neuronetics' therapy for depression to adolescents. Neuronetics announced that Evernorth will offer coverage for its NeuroStar Transcranial Magnetic ...
WRBL

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression

MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...
manilatimes

Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment ...

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

Detailed price information for Neuronetics Inc (STIM-Q) from The Globe and Mail including charting and trades.
EurekAlert!

Non-drug depression treatment rapidly and significantly improves disease symptoms and QoL

PHILADELPHIA, May 8, 2012 – New data released today at the annual meeting of the American Psychiatric Association show that patients with unipolar, non-psychotic Major Depressive Disorder (MDD) ...